Evicenter
Darzalex (daratumumab) in Multiple myeloma
Manufacturer
Janssen Biotech, Inc.
Questions
61
Last updated

All questions

Pharmacology: Darzalex (daratumumab) in multiple myeloma

4 questions · 3 sources

Mechanism

How does Darzalex (daratumumab) work in multiple myeloma (mechanism of action)?

What does the hyaluronidase in Darzalex Faspro do?

Note: The Support & Resources page also gives a half-life of 0.5 days for recombinant hyaluronidase, and the Dosing and Administration Guide gives a half-life in skin of less than 30 minutes; the Prescribing Information gives the 0.5-day half-life for hyaluronan.

Pharmacokinetics

What is the half-life of Darzalex (daratumumab)?

Note: The first passage is from the DARZALEX (intravenous) Prescribing Information; the second is from the DARZALEX FASPRO Prescribing Information.

Components

What are the inactive ingredients in Darzalex and Darzalex Faspro?

Note: Both passages are from the Description section of the Prescribing Information: the first for DARZALEX (intravenous), the second for DARZALEX FASPRO.